The Ohio State University Wexner Medical Center in Columbus has partnered with population genomics company Helix to launch the largest precision health initiative in the state.
Ohio State Genomic Health will launch later in 2024 and enroll 100,000 participants to participate in genetic screening for more than four years. The program will be optional and provided at no cost to participants, according to a July 23 news release from OSU Wexner Medical Center.
Helix's technology will be used to screen participants' genetic information for variants associated with breast and ovarian cancer, colorectal cancer and high cholesterol, the release said.
"This partnership will expand and accelerate research across Ohio State focused on understanding mechanisms underlying human disease as well as development of diagnostics and treatments for patients. This is a critical platform for prevention and treatment," Peter Mohler, PhD, executive vice president for research, innovation and knowledge at the university and chief scientific officer at OSU Wexner Medical Center, said in the release.